SARS-CoV-2: Only neutralising antibodies allow conclusions to be drawn about protection against new infections: Mutations of virus and illnesses caused by new variants are still to...
First-line immune defences against COVID-19 are short-lived and may explain reinfection. A new study finds that antibodies produced in the nose decline nine months after...